Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering ...

In a recent study, one-year MACE incidences were 1.79, 2.58, and 4.03 per 100 patient-years for early, late, and no ezetimibe added to statins.

Inflammation is likely a key player in atherosclerosis and related cardiovascular events, but questions remain about its role ...

Statin use in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma is associated with improved cancer ...

Most of us know someone who’s taking medicine to manage cholesterol levels, if we’re not the ones taking it ourselves. In ...